DGX
NYSE
$206.72
Quest Diagnostics Inc (DGX)
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $223.94 (+8.33%)
Market Cap
$22B
Forward P/E
19.61
P/E Ratio
22.47
Free Cash Flow Yield
5.97%
Price Chart
Valuation
Market Cap$22B
P/E22.47
Forward P/E19.61
PEG1.54
P/S1.98
P/B3.10
Profitability
Total Revenue (TTM)$11B
Gross Profit (TTM)$3.75B
EBITDA$2.19B
Profit Margin8.7%
Operating Margin13.8%
EPS$8.98
Financial Health
Debt-to-Equity6.8%
Free Cash Flow Yield5.97%
Dividend Yield1.56%
Growth & Risk
EPS 5Y CAGR+8.13%
Revenue 5Y CAGR+1.76%
FCF 5Y CAGR-8.50%
Dividends 5Y CAGR+7.06%
Beta (5Y)0.17
Sharpe Ratio0.92